Our Team @MpiciPotsdam as well as @GlycoUniverse are participating in the EU “Acinetwork” “A Training Network for the Design of Synthetic Carbohydrate-Based VaccinesAcinetobacter baumannii”.
We are offering one position for a PhD student https://t.co/96sj2HHKrY
We re expanding our very strong international team in Berlin by hiring a new PhD student in the area of molecular biology / vaccinology @BioMolSys@MpiciPotsdam working on the development of anti-bacterial vaccines
https://t.co/4E0nFd0oAX
Here we show that peptide-glycan chimera can be made on the same instrument on solid support. Next, an instrument to make #glycopeptides for #glycotime studies will be revealed.
It's #WorldPneumoniaDay#Pneumonia causes more than 1 in 10 deaths of children below 5 years of age, killing over 740000 per year.
#DYK? It is the single largest infectious cause of death in children worldwide? 🌎🌍🌏
👉https://t.co/jNgiyWcpsK
Working on understanding and perfecting one reaction - glycosylation - enabled the automation of oligosaccharide synthesis - access to pure glycans was the basis for the development of #vaccine candidates @MpiciPotsdam now developed @Idorsia
The @BMBF_Bund@SachsenDe and @sachsenanhalt just announced that the @CTC_Concept Center for the transformation of Chemistry will be funded with 1.25 billion Euros to create a new research center. Thanks to the colleagues that worked on the concept the universities and companies
Our multivalent glycopeptide array platform now works with various surfaces and high yield, enabling flexible lectin screening @FrontChemistry.
👇
https://t.co/7M9HyrLEdm
Congratulations @TsoukaAlexandra, @MpiciPotsdam@BioMolSys, Bernd Lepenies, @peterseeberger, and SAT group!